The US Drug Enforcement Administration (DEA) has publicly announced in the Federal Register that it is increasing its marijuana production quota from 21 kilograms to 650 kilograms (about 1,443 pounds) in order to meet increasing demand for the plant from clinical investigators.
For the second time in recent months, a scientific paper published in a peer-reviewed journal…
As I wrote last week in an op/ed for The Sacramento Bee, when it comes…
[Editor’s note: This post is excerpted from this today’s forthcoming NORML weekly media advisory. To…
Today marks the 10-year-anniversary of the publication of the Institute of Medicine’s landmark study on medical cannabis: Marijuana and Medicine: Assessing the Science Base.
When the White House commissioned this report in response to the passage of California’s Compassionate Use Act of 1996, many in the mainstream media, and many more lawmakers, were still skeptical about marijuana’s potential therapeutic value.
So if rats can deduce that whole cannabis works better as a medicine than a single synthesized molecule, what’s stopping our federal politicians and bureaucrats from reaching this same conclusion?
A funny thing happens when the US government begrudgingly allows for double-blind, placebo-controlled clinical trials evaluating the therapeutic efficacy of inhaled cannabis.
Investigators discover time after time that it works!